ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "H9c2"
H9c2
Osoba
Předměty
Osoby
Publikace
Studium
Exportovat aktuální pohled
PharmDr. Hana Jansová Ph.D.
Akademický pracovník na Farmaceutická fakulta v Hradci Králové
20 publikací
Publikace
publication
2,6-Dihydroxybenzaldehyde analogues of the iron chelator salicylaldehyde isonicotinoyl hydrazone: Increased hydrolytic stability and cytoprotective activity against oxidative stress
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?
2016 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
publication
Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products
2016 |
Farmaceutická fakulta v Hradci Králové
publication
Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury
2016 |
Farmaceutická fakulta v Hradci Králové
publication
Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents
2015 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
publication
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites
2015 |
Farmaceutická fakulta v Hradci Králové
publication
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
2014 |
Farmaceutická fakulta v Hradci Králové
publication
Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties
2014 |
Farmaceutická fakulta v Hradci Králové
publication
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
2022 |
Farmaceutická fakulta v Hradci Králové
publication
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase II beta inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
2021 |
Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
Načíst další publikace (10)
Loading network view...